

a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system.
| Headquarter | |
|---|---|
| Website | mindimmune.com/ |
| Founding Date | 2016 |
| Company Status | Private |
1 employee at MindImmune Therapeutics has reviewed MindImmune Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users about their company is that it was very prepared on their first day. Employees concluded that their overall onboarding experience was positive. 73% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no MindImmune Therapeutics employees have provided insight into whether or not they clearly understand MindImmune Therapeutics' KPIs and OKRs.

Bob Nelson Vice President of Exploratory Biology | Co-Founder
Bob Nelson serves as the Vice President of Exploratory Biology | Co-Founder of MindImmune Therapeutics, Inc.. Bob...

No Recent Jobs found for MindImmune Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is MindImmune Therapeutics eNPS?
The eNPS for MindImmune Therapeutics is -100